Skip to main content

AusPAR: Rybrevant

Australian Public Assessment Report
Device/Product Name
Rybrevant
Active ingredients
Amivantamab
AusPAR Date
Published
Submission Number
PM-2021-04814-1-4
Submission Type
New biological entity
Decision
Approved for provisional registration

Help us improve the Therapeutic Goods Administration site